21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cytotoxic and Enzyme Inhibitory Potential of Two Potentilla species ( P. speciosa L. and P. reptans Willd.) and Their Chemical Composition

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this work, the biological and chemical fingerprints of three extracts (ethyl acetate, methanol, and water) from two Potentilla species ( Potentilla reptans and P. speciosa) were investigated. Antioxidant, enzyme inhibitory, and cytotoxic activities were performed for the biological fingerprint. For the chemical characterization, total bioactive components, and individual phenolic components were determined using photometric and HPLC methods, respectively. The main identified phenolic compounds in these extracts were rutin and catechin. Methanol and water extracts contained the highest total phenolic and flavonoid content. The results of antioxidant assays showed that methanol and water extracts displayed higher antioxidant activity compared to the ethyl acetate extract. Generally, methanol and water extracts exhibited higher biological activities correlated with higher levels the bioactive components. For P. speciosa, the methanol extract exhibited the highest enzyme inhibitory activity (except BChE inhibitory activity). P. reptans exhibited also high antiproliferative activity against MCF-7 cells whilst P. speciosa had weak to moderate activity against both of A549 and MCF-7 cell lines. The results suggest that Potentilla species could be potential candidates for developing new phyto-pharmaceuticals and functional ingredients.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: not found
          • Article: not found

          In vitro antioxidant properties of rutin

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Treatment of Alzheimer's disease: current status and new perspectives.

            Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing. Pharmacological treatment of AD is based on the use of acetylcholinesterase inhibitors, which have beneficial effects on cognitive, functional, and behavioural symptoms of the disease, but their role in AD pathogenesis is unknown. Other pharmacological therapies are becoming available--including the recently approved drug memantine, an NMDA channel blocker indicated for advanced AD. Here, we review clinical features of the available cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) including their pharmacological properties, the evidence for switching from one agent to another, "head to head" studies, and the emerging evidence for the use of memantine in AD. New therapeutic approaches--including those more closely targeted to the pathogenesis of the disease--will also be reviewed. These potentially disease modifying treatments include amyloid-beta-peptide vaccination, secretase inhibitors, cholesterol-lowering drugs, metal chelators, and anti-inflammatory agents.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase.

              The increasing prevalence of type 2 diabetes mellitus and the negative clinical outcomes observed with the commercially available anti-diabetic drugs have led to the investigation of new therapeutic approaches focused on controlling postprandrial glucose levels. The use of carbohydrate digestive enzyme inhibitors from natural resources could be a possible strategy to block dietary carbohydrate absorption with less adverse effects than synthetic drugs. This review covers the latest evidence regarding in vitro and in vivo studies in relation to pancreatic alpha-amylase inhibitors of plant origin, and presents bioactive compounds of phenolic nature that exhibit anti-amylase activity. Pancreatic alpha-amylase inhibitors from traditional plant extracts are a promising tool for diabetes treatment. Many studies have confirmed the alpha-amylase inhibitory activity of plants and their bioactive compounds in vitro, but few studies corroborate these findings in rodents and very few in humans. Thus, despite some encouraging results, more research is required for developing a valuable anti-diabetic therapy using pancreatic alpha-amylase inhibitors of plant origin.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                23 May 2017
                2017
                : 8
                : 290
                Affiliations
                [1] 1Department of Biology, Science Faculty, Selcuk University, Campus Konya, Turkey
                [2] 2Department of Pharmacy, University “G. d’Annunzio” Chieti-Pescara Chieti, Italy
                [3] 3Interuniversity Consortium of Structural and Systems Biology Rome, Italy
                [4] 4Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences Tabriz, Iran
                [5] 5Department of Pharmaceutical Botany, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania
                Author notes

                Edited by: Jianbo Xiao, University of Macau, China

                Reviewed by: Elena Gonzalez Burgos, Complutense University of Madrid, Spain; Zhaojun Wei, Hefei University of Technology, China

                *Correspondence: Sengul Uysal, sennguluysal@ 123456gmail.com Andrei Mocan, mocan.andrei@ 123456umfcluj.ro

                This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

                Article
                10.3389/fphar.2017.00290
                5441381
                28588492
                9593d2e3-c733-4854-93a4-8367ddda1cd9
                Copyright © 2017 Uysal, Zengin, Locatelli, Bahadori, Mocan, Bellagamba, De Luca, Mollica and Aktumsek.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 December 2016
                : 05 May 2017
                Page count
                Figures: 2, Tables: 5, Equations: 0, References: 69, Pages: 11, Words: 0
                Categories
                Pharmacology
                Original Research

                Pharmacology & Pharmaceutical medicine
                potentilla reptans,p. speciosa,antioxidant activity,enzyme inhibitory activity,cytotoxic

                Comments

                Comment on this article